HighTower Advisors LLC Acquires 44,482 Shares of Colgate-Palmolive (NYSE:CL)

HighTower Advisors LLC boosted its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 4.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 970,040 shares of the company's stock after buying an additional 44,482 shares during the period. HighTower Advisors LLC owned approximately 0.12% of Colgate-Palmolive worth $100,689,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the business. E Fund Management Hong Kong Co. Ltd. acquired a new stake in Colgate-Palmolive in the second quarter worth $25,000. Continuum Advisory LLC raised its holdings in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive in the third quarter worth $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive in the third quarter worth $53,000. Finally, Prospera Private Wealth LLC acquired a new stake in Colgate-Palmolive in the third quarter worth $64,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently commented on CL. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Monday, November 25th. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. UBS Group raised their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Finally, Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $105.11.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded up $0.20 during midday trading on Wednesday, hitting $94.81. The company's stock had a trading volume of 3,971,765 shares, compared to its average volume of 4,384,240. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a 50-day moving average price of $96.89 and a two-hundred day moving average price of $98.63. The company has a market cap of $77.46 billion, a price-to-earnings ratio of 27.17, a PEG ratio of 3.47 and a beta of 0.43.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.11%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive's dividend payout ratio (DPR) is 57.31%.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.37% of the company's stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.